Fundz

Amytrx Therapeutics Raises $18M For New Therapeutic Interventions Of Atopic Dermatitis

PRIVATEMay 25, 2022

Amount Raised

$18 Million

Round Type

Funding Round

NashvilleHealthcareHealth Care

Description

Amytrx Therapeutics, a mission-driven biopharmaceutical company dedicated to transformative and cutting-edge immune-modulating therapeutics that safely alter the course of chronic inflammatory disorders, announces today it has concluded its $18M in Series A financing with participation from both existing and new investors. This funding is dedicated to continuing clinical research on the use of their next-generation anti-inflammatory therapeutic peptide platform, AMTX-100, across several skin inflammatory disorders in adults and adolescents.

Quick answer

Amytrx Therapeutics raised $18 Million in a Funding Round round, dated May 25, 2022. Amytrx Therapeutics is based in Nashville, Tennessee, United States.

How much did Amytrx Therapeutics raise?
Amytrx Therapeutics raised $18 Million in a Funding Round round on May 25, 2022.
What does Amytrx Therapeutics do?
Amytrx is a clinical-stage biopharmaceutical company pioneering the first anti-inflammatory human peptide platform (AMTX-100) yielding the potential for vastly optimized, cutting-edge therapies that safely alter the..
Where is Amytrx Therapeutics based and how big is it?
Amytrx Therapeutics is based in Nashville, Tennessee, United States.
Who are the decision-makers at Amytrx Therapeutics?
Fundz holds 1 contact at Amytrx Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Health Care around the same time

Companies in the same sectors as Amytrx Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • MR3 Health raised $120K (Seed) on July 8, 2022.
  • MR3 Health raised $690K (Seed) on July 8, 2022.
  • Imagen Dental Partners raised $457K on July 8, 2022.
  • MediBeacon raised $8.1M on July 8, 2022.
  • Jaguar Health raised $300K on July 8, 2022.
  • Kernal Biologics raised $25M (Series A) on July 7, 2022.

Who to call at Amytrx Therapeutics, and when

A new round usually means Amytrx Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Amytrx Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Amytrx Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Amytrx Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Amytrx Therapeutics

Location

Nashville, Tennessee, United States

About

Amytrx is a clinical-stage biopharmaceutical company pioneering the first anti-inflammatory human peptide platform (AMTX-100) yielding the potential for vastly optimized, cutting-edge therapies that safely alter the course of chronic inflammation and metabolic dysfunction to prevent and treat some of the world's most debilitating diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Amytrx Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts16 people are listed at Amytrx Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Amytrx Therapeutics's next move

See what Strategic adds

Amytrx Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.